Abstract
The French medical device market is increasingly supplied by the foreign sales
subsidiaries of multinational companies, several of which manufacture within
France having bought up smaller indigenous firms. This report is ideal for
executives wanting to understand the key drivers in the medical market and
have access to a wealth of statistical data, including five-year market
projections. Included with the report are 3 free quarterly updated outlook
reports, enabling you to keep up to date with market developments for a year.
Includes 3 quarterly updated outlook reports!
France is the fourth largest medical device market in the world, ranking
behind the USA, Japan and Germany. The French medical device market is
increasingly supplied by the foreign sales subsidiaries of multinational
companies, several of which manufacture within France having bought up smaller
indigenous firms. Many distributors are also involved in re-exporting to
French-speaking Africa.
Medical device imports reached US$8.1 billion in 2006, although not all
imported products are destined for the domestic market. In recent years,
imports have grown at a faster rate than the overall market; due partly to a
rise in re-exports in certain sectors, most notably pacemakers.
The continuing deficit of the national health insurance funds, which finance
the majority of health expenditure, has prompted a series of reform programmes
for the health sector. The latest has been drawn up by the new president,
Nicolas Sarkozy, who took office in May 2007.
New measures have recently been taken to control spending on medical devices,
similar to those already in force for pharmaceuticals. For this reason, the
medical market is only likely to see moderate growth, rising from US$7.52
billion in 2007 to US$9.75 billion by 2012.
Prospects for medical equipment manufacturers remain promising as a result of
several initiatives intended to allow France to make good its shortfall in
some equipment areas, most notably imaging and radiotherapy equipment, as part
of a ten billion euro hospital investment programme. A second programme with
similar levels of investment is set to run from 2008-2012.